Last mentioned: Mar 20, 2026
Target IPO Window
Reports suggest Elon Musk is aiming for a public listing or major capital raise at a $1.75T valuation.
Potential IPO Window
Target date for SpaceX to go public at a $1.75T+ valuation.
Target IPO Window
SpaceX reportedly eyes June for its initial public offering at a $1.75T valuation.
10M Milestone
Starlink officially surpasses 10 million active subscribers across 155+ markets.
10 Million Mark
Starlink officially surpasses 10 million global subscribers.
10 Million Mark
Starlink officially surpasses 10 million global subscribers.
9M Subscribers
Rapid global expansion leads to a near-doubling of the user base within 12 months.
Rapid Expansion
Subscriber count nearly doubles to over 9 million by the end of 2025.
Growth Acceleration
Subscriber count doubles to over 9 million within 12 months.
4.6M Subscribers
Starlink ends the year with a strong foothold in the satellite internet market.
Subscriber Milestone
Starlink ends the year with approximately 4.6 million subscribers.
Subscriber Milestone
Starlink ends the year with 4.6 million subscribers.
Rocket Lab (RKLB) has recorded a 238% stock price increase over the past year, driven by a record launch cadence and the rapid development of its medium-lift Neutron rocket. The company is successfully transitioning from a niche small-satellite launcher into a vertically integrated space systems powerhouse, positioning it as the primary public-market alternative to SpaceX.
A significant wave of analyst rating changes has hit the market, featuring a notable downgrade for boutique fitness giant Xponential Fitness and a bullish initiation for space leader Rocket Lab. These shifts underscore a broader institutional reassessment of growth trajectories across the fitness, aerospace, and biotechnology sectors.
Apogee Therapeutics and Arcturus Therapeutics experienced a wave of conflicting analyst activity on Thursday, with both companies facing significant downgrades alongside new initiations. This institutional tug-of-war highlights the increasing volatility and selective nature of investment in mid-cap biotechnology firms.
Apogee Therapeutics and Arcturus Therapeutics faced simultaneous downgrades and initiations in a single trading session, highlighting a sharp divide in analyst sentiment. This volatility reflects broader market uncertainty regarding clinical-stage biotech valuations and the specific pipelines of these immunology and mRNA specialists.
SpaceX is reportedly preparing for a June 2026 IPO that could value the aerospace giant at over $1.75 trillion. Driven by Starlink's explosive growth to 10 million subscribers, the move highlights the massive scale of Elon Musk's vertically integrated space economy.
SpaceX is reportedly preparing for a June 2026 IPO that could value the aerospace giant at over $1.75 trillion, driven by the explosive growth of its Starlink satellite internet division. With over 10 million subscribers and a vertically integrated launch model, the offering represents a pivotal moment for the commercial space industry.
SpaceX is reportedly preparing for a landmark initial public offering as early as June 2026, targeting a valuation exceeding $1.75 trillion. Driven by Starlink's explosive growth to over 10 million subscribers, the move signals a shift from private venture to a dominant public force in the global telecommunications and aerospace sectors.
Rocket Lab (RKLB) has introduced a new line of silicon-based solar arrays specifically engineered for the high-power demands of space-based data centers. This strategic expansion of their Space Systems portfolio targets the growing market for orbital edge computing and large-scale satellite constellations.